Cargando…
Corrigendum: Pan-Cancer Analysis Shows That ALKBH5 Is a Potential Prognostic and Immunotherapeutic Biomarker for Multiple Cancer Types Including Gliomas
| Autores principales: | , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9261734/ https://www.ncbi.nlm.nih.gov/pubmed/35812444 http://dx.doi.org/10.3389/fimmu.2022.944740 |
| _version_ | 1784742341897093120 |
|---|---|
| author | Wei, Cheng Wang, Bo Peng, Dazhao Zhang, Xiaoyang Li, Zesheng Luo, Lin He, Yingjie Liang, Hao Du, Xuezhi Li, Shenghui Zhang, Shu Zhang, Zhenyu Han, Lei Zhang, Jianning |
| author_facet | Wei, Cheng Wang, Bo Peng, Dazhao Zhang, Xiaoyang Li, Zesheng Luo, Lin He, Yingjie Liang, Hao Du, Xuezhi Li, Shenghui Zhang, Shu Zhang, Zhenyu Han, Lei Zhang, Jianning |
| author_sort | Wei, Cheng |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9261734 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Frontiers Media S.A. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-92617342022-07-08 Corrigendum: Pan-Cancer Analysis Shows That ALKBH5 Is a Potential Prognostic and Immunotherapeutic Biomarker for Multiple Cancer Types Including Gliomas Wei, Cheng Wang, Bo Peng, Dazhao Zhang, Xiaoyang Li, Zesheng Luo, Lin He, Yingjie Liang, Hao Du, Xuezhi Li, Shenghui Zhang, Shu Zhang, Zhenyu Han, Lei Zhang, Jianning Front Immunol Immunology Frontiers Media S.A. 2022-06-23 /pmc/articles/PMC9261734/ /pubmed/35812444 http://dx.doi.org/10.3389/fimmu.2022.944740 Text en Copyright © 2022 Wei, Wang, Peng, Zhang, Li, Luo, He, Liang, Du, Li, Zhang, Zhang, Han and Zhang https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
| spellingShingle | Immunology Wei, Cheng Wang, Bo Peng, Dazhao Zhang, Xiaoyang Li, Zesheng Luo, Lin He, Yingjie Liang, Hao Du, Xuezhi Li, Shenghui Zhang, Shu Zhang, Zhenyu Han, Lei Zhang, Jianning Corrigendum: Pan-Cancer Analysis Shows That ALKBH5 Is a Potential Prognostic and Immunotherapeutic Biomarker for Multiple Cancer Types Including Gliomas |
| title | Corrigendum: Pan-Cancer Analysis Shows That ALKBH5 Is a Potential Prognostic and Immunotherapeutic Biomarker for Multiple Cancer Types Including Gliomas |
| title_full | Corrigendum: Pan-Cancer Analysis Shows That ALKBH5 Is a Potential Prognostic and Immunotherapeutic Biomarker for Multiple Cancer Types Including Gliomas |
| title_fullStr | Corrigendum: Pan-Cancer Analysis Shows That ALKBH5 Is a Potential Prognostic and Immunotherapeutic Biomarker for Multiple Cancer Types Including Gliomas |
| title_full_unstemmed | Corrigendum: Pan-Cancer Analysis Shows That ALKBH5 Is a Potential Prognostic and Immunotherapeutic Biomarker for Multiple Cancer Types Including Gliomas |
| title_short | Corrigendum: Pan-Cancer Analysis Shows That ALKBH5 Is a Potential Prognostic and Immunotherapeutic Biomarker for Multiple Cancer Types Including Gliomas |
| title_sort | corrigendum: pan-cancer analysis shows that alkbh5 is a potential prognostic and immunotherapeutic biomarker for multiple cancer types including gliomas |
| topic | Immunology |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9261734/ https://www.ncbi.nlm.nih.gov/pubmed/35812444 http://dx.doi.org/10.3389/fimmu.2022.944740 |
| work_keys_str_mv | AT weicheng corrigendumpancanceranalysisshowsthatalkbh5isapotentialprognosticandimmunotherapeuticbiomarkerformultiplecancertypesincludinggliomas AT wangbo corrigendumpancanceranalysisshowsthatalkbh5isapotentialprognosticandimmunotherapeuticbiomarkerformultiplecancertypesincludinggliomas AT pengdazhao corrigendumpancanceranalysisshowsthatalkbh5isapotentialprognosticandimmunotherapeuticbiomarkerformultiplecancertypesincludinggliomas AT zhangxiaoyang corrigendumpancanceranalysisshowsthatalkbh5isapotentialprognosticandimmunotherapeuticbiomarkerformultiplecancertypesincludinggliomas AT lizesheng corrigendumpancanceranalysisshowsthatalkbh5isapotentialprognosticandimmunotherapeuticbiomarkerformultiplecancertypesincludinggliomas AT luolin corrigendumpancanceranalysisshowsthatalkbh5isapotentialprognosticandimmunotherapeuticbiomarkerformultiplecancertypesincludinggliomas AT heyingjie corrigendumpancanceranalysisshowsthatalkbh5isapotentialprognosticandimmunotherapeuticbiomarkerformultiplecancertypesincludinggliomas AT lianghao corrigendumpancanceranalysisshowsthatalkbh5isapotentialprognosticandimmunotherapeuticbiomarkerformultiplecancertypesincludinggliomas AT duxuezhi corrigendumpancanceranalysisshowsthatalkbh5isapotentialprognosticandimmunotherapeuticbiomarkerformultiplecancertypesincludinggliomas AT lishenghui corrigendumpancanceranalysisshowsthatalkbh5isapotentialprognosticandimmunotherapeuticbiomarkerformultiplecancertypesincludinggliomas AT zhangshu corrigendumpancanceranalysisshowsthatalkbh5isapotentialprognosticandimmunotherapeuticbiomarkerformultiplecancertypesincludinggliomas AT zhangzhenyu corrigendumpancanceranalysisshowsthatalkbh5isapotentialprognosticandimmunotherapeuticbiomarkerformultiplecancertypesincludinggliomas AT hanlei corrigendumpancanceranalysisshowsthatalkbh5isapotentialprognosticandimmunotherapeuticbiomarkerformultiplecancertypesincludinggliomas AT zhangjianning corrigendumpancanceranalysisshowsthatalkbh5isapotentialprognosticandimmunotherapeuticbiomarkerformultiplecancertypesincludinggliomas |